NIH Drops Super-Vaccines: 100% Mouse Protection Against Malaria!
Published Date: 3/9/2026
Notice
Summary
The National Institutes of Health is offering new malaria vaccine inventions for companies to license and develop. These cool nanoparticle platforms show promise in making vaccines super effective, with early tests in mice showing 100% protection. If you’re a business or researcher ready to jump in, now’s the time to connect and start working with these government-owned inventions!
Analyzed Economic Effects
4 provisions identified: 4 benefits, 0 costs, 0 mixed.
NIH Offers Malaria Vaccine Tech For Licensing
The National Institute of Allergy and Infectious Diseases (NIAID/NIH) is offering three engineered nanoparticle vaccine platforms for licensing and commercial development under 35 U.S.C. 209 and 37 CFR part 404. The platforms include a PLP synthase nanoparticle displaying 48 copies of up to 4 proteins, a Cpn60 nanoparticle displaying 28 copies of up to 2 proteins, and a Clp nanoparticle displaying 28 copies of up to 2 proteins. To get unpublished information or pursue a license, contact Chris Kornak (240-565-2632, [email protected]) and a signed Confidential Disclosure Agreement is required; reference HHS Ref. No. E-182-2024-0.
Patent Filings Cover Technology
The technology is covered by patent filings: U.S. Provisional Patent Application No. 63/695,288 filed on September 16, 2024, and PCT Patent Application No. PCT/US2025/046419 filed on September 15, 2025. The notice says foreign patent applications have been filed on selected inventions to extend market coverage and those patent rights may be available for licensing.
Pre-Clinical Data Shows 100% Protection In Mice
Pre-clinical data reported in the notice show that nanoparticles displaying the malaria circumsporozoite protein (CSP) conferred 100% sterilizing immunity in mice, and the work is described as being at the pre-clinical developmental stage. The publication cited is: Shi D, et al., Nat Microbiol. 2026;11(1):67-80, doi:10.1038/s41564-025-02209-y.
Opportunity For Collaborative Research
NIAID is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize these malaria vaccine nanoparticle technologies. Interested parties should contact Chris Kornak at 240-565-2632 or [email protected] to express interest.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-22871, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in early December 2026 to review and evaluate grant applications. These meetings affect researchers and small businesses seeking funding for eye disease, neuronal injury, infectious diseases, and related projects. No public access is allowed to protect private info and trade secrets, but these reviews help decide who gets research money.
2026-22550, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding two closed virtual meetings on November 30, 2026, to review important grant applications. These meetings affect researchers applying for funding in cardiovascular sciences and tobacco regulatory science. No public access is allowed to protect private info and trade secrets, and the reviews help decide who gets research money.
2026-22558, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in early December 2026 to review and evaluate grant applications. These meetings affect researchers and small businesses seeking funding for health-related projects, ensuring privacy for sensitive information. No direct money changes are announced, but these reviews help decide who gets research grants.
2026-22339, Prospective Grant of Exclusive Patent License: Catheter-Based Intramyocardial Ablation for Treating Ventricular Arrhythmia in a Human
The National Institutes of Health plans to give AntaraCore Systems, Inc. an exclusive license to use new catheter technology that treats dangerous heart rhythm problems called ventricular arrhythmia. This means AntaraCore will have special rights to develop and sell this life-saving treatment. If you want to comment or apply for a license, you must do so by December 2, 2026.
2026-22196, National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting
The National Institute of Diabetes and Digestive and Kidney Diseases is holding a public meeting on May 12, 2027, to discuss important council business and review grant applications. People interested can attend in person or online, but space is limited and some parts of the meeting will be private to protect sensitive information. This meeting affects researchers and organizations seeking funding and sets the stage for future diabetes and kidney disease research support.
2026-22111, Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting
The Eunice Kennedy Shriver National Institute of Child Health & Human Development is holding a virtual meeting on June 4, 2027, to share updates and review grant applications and staff performance. The first half is open to the public, while the second half is private to protect personal privacy. This meeting affects researchers and staff involved with NICHD grants and projects, with no direct cost changes announced.
Previous / Next Documents
Previous: 2026-04530, Agency Information Collection Activities; Submission to the Office of Management and Budget (OMB) for Review and Approval; Comment Request; Basic Requirements for Special Exception Permits and Authorizations To Take, Import, and Export Marine Mammals, Threatened and Endangered Species, and for Maintaining a Captive Marine Mammal Inventory Under Section 104 of the Marine Mammal Protection Act, the Fur Seal Act, and/or Section 10(a)(1)(A) of the Endangered Species Act
NOAA is asking for public feedback on updating the paperwork rules for permits involving marine mammals and endangered species. This affects researchers, businesses, and organizations that take, import, export, or keep these animals. Comments are open until May 8, 2026, helping keep the process clear and efficient without adding extra costs or delays.
Next: 2026-04535, Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; HRSA Ryan White HIV/AIDS Program Part F National AIDS Education and Training Center Program Activities, OMB No. 0906-XXXX-New
HRSA is asking for public feedback on a new info collection about the Ryan White HIV/AIDS Program’s training centers. These centers help healthcare workers learn how to better prevent and treat HIV with updated education and support. Comments are open until April 8, 2026, and this review helps keep the program effective without adding extra paperwork or costs.